Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cora N Sternberg

Showing results (111-120 of 357) with videos related to

Pageof 36
Sort By:
Cancer Treatment Reviews|May 23, 2018
The role of bisphosphonates or denosumab in light of the availability of new therapies for prostate cancerFred Saad, Cora N Sternberg, Peter F A Mulders, et al.
Oncology|June 20, 2015
Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients with Advanced Renal Cell Carcinoma Treated with PazopanibMichael W Kattan, Cora N Sternberg, Faisal Mehmud, et al.
BJU International|November 30, 2021
Application of artificial intelligence to overcome clinical information overload in urological cancerArnulf Stenzl, Cora N Sternberg, Jenny Ghith, et al.
BMC Urology|November 12, 2013
Treatment patterns and characteristics of European patients with castration-resistant prostate cancerCora N Sternberg, Edwina S Baskin-Bey, Mark Watson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Reply to S. Barni et Al and M. Sun et AlBernard Escudier, Camillo Porta, Thomas Powles, et al.
Current Drug Targets|November 21, 2014
Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer: a systematic review and meta-analysisRoberto Iacovelli, Cora N Sternberg, Camillo Porta, et al.
Oncology and Therapy|November 4, 2025
Evaluation of Event-Free Survival as a Surrogate Endpoint for Overall Survival in Muscle-Invasive Bladder Cancer Following Neoadjuvant Treatment: A Systematic Review and Meta-AnalysisCora N Sternberg, Patrick Squires, Yan Song, et al.
Critical Reviews in Oncology/Hematology|August 14, 2010
Sequential use of targeted agents in the treatment of renal cell carcinomaThomas E Hutson, Ronald M Bukowski, C Lance Cowey, et al.
European Urology|May 10, 2011
The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literatureGuru Sonpavde, Gerhardt Attard, Joaquim Bellmunt, et al.
Journal of the National Cancer Institute|January 12, 2012
Targeted therapies for renal cell carcinoma: review of adverse event management strategiesTim Eisen, Cora N Sternberg, Caroline Robert, et al.
Pageof 36

Showing results (111-120 of 357) with videos related to

Sort By:
Pageof 36
Cancer Treatment Reviews|May 23, 2018
The role of bisphosphonates or denosumab in light of the availability of new therapies for prostate cancerFred Saad, Cora N Sternberg, Peter F A Mulders, et al.
Oncology|June 20, 2015
Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients with Advanced Renal Cell Carcinoma Treated with PazopanibMichael W Kattan, Cora N Sternberg, Faisal Mehmud, et al.
BJU International|November 30, 2021
Application of artificial intelligence to overcome clinical information overload in urological cancerArnulf Stenzl, Cora N Sternberg, Jenny Ghith, et al.
BMC Urology|November 12, 2013
Treatment patterns and characteristics of European patients with castration-resistant prostate cancerCora N Sternberg, Edwina S Baskin-Bey, Mark Watson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Reply to S. Barni et Al and M. Sun et AlBernard Escudier, Camillo Porta, Thomas Powles, et al.
Current Drug Targets|November 21, 2014
Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer: a systematic review and meta-analysisRoberto Iacovelli, Cora N Sternberg, Camillo Porta, et al.
Oncology and Therapy|November 4, 2025
Evaluation of Event-Free Survival as a Surrogate Endpoint for Overall Survival in Muscle-Invasive Bladder Cancer Following Neoadjuvant Treatment: A Systematic Review and Meta-AnalysisCora N Sternberg, Patrick Squires, Yan Song, et al.
Critical Reviews in Oncology/Hematology|August 14, 2010
Sequential use of targeted agents in the treatment of renal cell carcinomaThomas E Hutson, Ronald M Bukowski, C Lance Cowey, et al.
European Urology|May 10, 2011
The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literatureGuru Sonpavde, Gerhardt Attard, Joaquim Bellmunt, et al.
Journal of the National Cancer Institute|January 12, 2012
Targeted therapies for renal cell carcinoma: review of adverse event management strategiesTim Eisen, Cora N Sternberg, Caroline Robert, et al.
Pageof 36